. Saba Aidah; . Syed Wasif Gillani; . Afifa Alderazi; . Fawaz Abdulazeez
Volume 11, Issue 5 , June 2021, , Pages 1-8
Abstract
Medication errors (MEs) are a critical worldwide concern and can cause genuine clinical ramificationsfor patients. Studies concerning such errors have not been undertaken as much in ...
Read More
Medication errors (MEs) are a critical worldwide concern and can cause genuine clinical ramificationsfor patients. Studies concerning such errors have not been undertaken as much in the MiddleEastern region. The aim of this study was to systematically review and identify studies done in theMiddle Eastern nations to recognize the principle contributory factors included and to estimate theprevalence in the region. A review of the retrospective, prospective, cohort, and case–control studiesbased on MEs in the Middle Eastern nations was directed in January 2020 utilizing the accompanyingdatabases: Embase, Medline, PubMed, Ebsco, Cochrane, Scopus, and Prospero. The searchmethodology incorporated all ages and in English only dating back to 2010. The search methodologyincluded articles about MEs in the Middle East with errors in people of all ages, articles in English,and articles dating back to 2010. The Preferred Reporting Items for Systematic Reviews and MetaAnalyses appraisal instrument was used to assess the quality of the included articles. Individualdata extraction, pooled analysis, and the accompanying databases were used for data analysis ofthe MEs in eligible studies. Fifteen of the 18 articles reviewed from four Middle Eastern countrieshad low risk of bias, while three out of 18 had medium risk of bias. A total of 58,221 reported peoplewere studied, with a total of 34,730.9 reported MEs. The pooled analysis showed that numbers oferrors were mainly prescribing errors (n = 22,715.25), general prescription errors (n = 8097.16), andcommission errors (n = 158.2). Iran had the highest rate amid the reported administration errors, at25.07% (599.11/2388.9). Measuring a patient’s clinical laboratory values was another less commontype of prescription ME. Lebanon reported to have the highest monitoring errors, with a rate of 13.13%(277.91/2117). A negative trend was shown in the amount of MEs in the vast majority of the nationsunder the examination. The under-reporting or uncertain information recommended that significanchanges are needed in the healthcare sector. There is solid need of literature on healthcare servicesin the region to completely understand and address the MEs and issues.